Table 1.
Marker | AJCC stage of patients with melanoma % (n)
|
|||||
---|---|---|---|---|---|---|
0 | I | II | III | IV | Healthy controls | |
MLANA | 26 (10) | 25 (19) | 18 (7) | 40 (12) | 43 (20) | 13 (19) |
ABCB5 | 45 (17) | 27 (21) | 33 (13) | 50 (15) | 52 (24) | 22 (33) |
PAX3d | 47 (18) | 30 (23) | 36 (14) | 50 (15) | 46 (21) | 14 (21) |
MCAM | 42 (16) | 49 (38) | 46 (18) | 53 (16) | 43 (20) | 14 (21) |
TGFβ2 | 63 (24) | 64 (49) | 74 (29) | 77 (23) | 59 (27) | 22 (33) |
N | 38 | 77 | 39 | 30 | 46 | 152 |